Builds foundation models for biomolecular structure prediction and fully de novo antibody design.
Computational de novo protein and enzyme design company spun out of David Baker's University of Washington lab.
Including Funding rounds + valuations, Founders + executives, Products + tech stack, Headcount + HQ, Status timeline, and Roster connections.
Already subscribed? Sign in →